Published in J Clin Invest on March 01, 1992
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A (1997) 5.54
RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med (1992) 3.25
Airway responses to aerosolized brevetoxins in an animal model of asthma. Am J Respir Crit Care Med (2004) 2.40
Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest (1995) 2.29
Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med (1994) 2.29
Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol (1998) 1.88
Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med (1996) 1.71
Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1. J Exp Med (1993) 1.52
Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med (1997) 1.43
Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med (1996) 1.38
Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J Exp Med (1992) 1.27
Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect Immun (1994) 1.22
Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation. Am J Pathol (1995) 1.20
Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med (1996) 1.12
Chemokines and chemokine receptors: their role in allergic airway disease. J Clin Immunol (1999) 0.95
Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT release. Immunology (1995) 0.91
Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2. Respir Res (2004) 0.91
Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat. Am J Pathol (1995) 0.85
Immunological events in chronic spontaneous urticaria. Clin Transl Allergy (2015) 0.79
Progress and challenges in the understanding of chronic urticaria. Allergy Asthma Clin Immunol (2007) 0.78
Blood histamine levels (BHL) in infants and children with respiratory and non-respiratory diseases. Mediators Inflamm (2001) 0.75
Analysis of monocyte chemoattractant protein 1-mediated lung injury using rat lung organ cultures. Am J Pathol (1993) 0.75
The Effect of Transcutaneous Electrical Acupoint Stimulation on Inflammatory Response in Patients Undergoing Limb Ischemia-Reperfusion. Mediators Inflamm (2017) 0.75
Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett (1989) 4.75
Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today (1990) 3.31
Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem Biophys Res Commun (1989) 3.09
Role of secretory events in modulating human neutrophil chemotaxis. J Clin Invest (1978) 2.59
Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med (1990) 2.40
Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med (1989) 2.34
Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med (1985) 1.84
Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release. J Immunol (1983) 1.63
Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest (1988) 1.50
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol (1987) 1.32
Recombinant IL-3 induces histamine release from human basophils. J Immunol (1989) 1.31
The magnitude of the spontaneous production of histamine-releasing factor (HRF) by lymphocytes in vitro correlates with the state of bronchial hyperreactivity in patients with asthma. J Allergy Clin Immunol (1987) 1.07
Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. J Immunol (1986) 1.07
Purification and further characterization of human mononuclear cell histamine-releasing factor. J Clin Invest (1989) 1.06
Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells. J Immunol (1989) 0.98
Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor. J Immunol (1976) 0.97
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. J Clin Invest (1990) 0.92
Detection of histamine release inhibitory factor- and histamine releasing factor-like activities in bronchoalveolar lavage fluids. Am Rev Respir Dis (1990) 0.86
Sensitivity of basophils to histamine releasing factor(s) of various origin: dependency on allergic phenotype of the donor and surface-bound IgE. J Allergy Clin Immunol (1990) 0.82
Wilderness and biodiversity conservation. Proc Natl Acad Sci U S A (2003) 3.36
Hereditary angioedema: its diagnostic and management perspectives. Am J Med (1990) 2.50
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg (2001) 2.38
Introducing a drug formulary to general practice--effects on practice prescribing costs. J R Coll Gen Pract (1987) 2.24
Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation. Nature (1979) 2.17
Quantitative evaluation of a screening program. Am J Public Health (1974) 2.00
Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med (1996) 1.75
Contribution of general practitioner hospitals in Scotland. Br Med J (Clin Res Ed) (1984) 1.74
Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol (1979) 1.72
A closer look at water-related geologic activity on Mars. Science (2007) 1.71
Volatile and organic compositions of sedimentary rocks in Yellowknife Bay, Gale crater, Mars. Science (2013) 1.65
Community hospitals--time to come off the fence. J R Coll Gen Pract (1989) 1.57
Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology (1990) 1.52
Hydrated silicate minerals on Mars observed by the Mars Reconnaissance Orbiter CRISM instrument. Nature (2008) 1.52
Refractory cholinergic urticaria successfully treated with ketotifen. J Allergy Clin Immunol (1989) 1.52
Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood (2000) 1.51
RANTES is a chemotactic and activating factor for human eosinophils. J Immunol (1993) 1.49
Genetic variation among dengue 2 viruses of different geographic origin. Virology (1983) 1.48
Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes: a possible role in the mechanism of virus-induced asthma. J Infect Dis (1991) 1.43
Monstrous, crablike hypertrophy of the cerebellar vermis and its relationship with Lhermitte-Duclos disease. Case report. J Neurosurg (1996) 1.39
Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b. Virology (1987) 1.34
Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J Exp Med (1992) 1.27
Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol (1984) 1.26
The intrinsic helix-forming tendency of L-alanine. Proc Natl Acad Sci U S A (1992) 1.26
Complement-mediated release of histamine from human leukocytes. J Immunol (1975) 1.20
Personal accounts of the role of God in health and illness among older rural African American and White residents. J Cross Cult Gerontol (2000) 1.17
Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization. J Immunol (1979) 1.15
Elemental geochemistry of sedimentary rocks at Yellowknife Bay, Gale crater, Mars. Science (2013) 1.14
Genetic variation and microevolution of dengue 2 virus in Southeast Asia. Virology (1989) 1.13
Spinal lipomas in children: outcome of 270 procedures. Pediatr Neurosurg (1997) 1.11
Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br J Pharmacol (1980) 1.10
Simultaneous generation of tuberculin-type and cutaneous basophilic hypersensitivity at separate sites in the guinea pig. Int Arch Allergy Appl Immunol (1979) 1.09
Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J Allergy Clin Immunol (1997) 1.08
Geographic classification of dengue-2 virus strains by antigen signature analysis. Virology (1986) 1.08
Mindfulness meditation-related pain relief: evidence for unique brain mechanisms in the regulation of pain. Neurosci Lett (2012) 1.08
Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J Immunol (1997) 1.08
'Idiopathic' nephrotic syndrome is not always idiopathic. Tex Med (1990) 1.07
Complement-mediated release of histamine from human basophils. II. Biochemical characterization of the reaction. J Immunol (1976) 1.05
In situ radiometric and exposure age dating of the martian surface. Science (2013) 1.03
The Opportunity Rover's Athena science investigation at Meridiani Planum, Mars. Science (2004) 1.03
High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med (1996) 1.02
Partial amino acid sequences of chicken and turkey immunoglobulin light chains. Homology with mammalian lambda chains. Biochemistry (1971) 0.99
Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol (1994) 0.99
A comparison of New World alphaviruses in the western equine encephalomyelitis complex by immunochemical and oligonucleotide fingerprint techniques. J Gen Virol (1980) 0.98
Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells. J Immunol (1989) 0.98
Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J Infect Dis (1994) 0.97
Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor. J Immunol (1976) 0.97
Release of slow reacting substance of anaphylaxis from human leukocytes. J Immunol (1974) 0.97
Positive interaction between agonists in the aggregation response of human blood platelets: interation between ADP, adrenaline and vasopressin. Br J Haematol (1980) 0.95
Histamine-induced inhibition of normal human basophil chemotaxis to C5a. J Immunol (1977) 0.94
Unsuspected benzyl alcohol hypersensitivity. N Engl J Med (1982) 0.92
The Spirit Rover's Athena science investigation at Gusev Crater, Mars. Science (2004) 0.92
Generation of slow reacting substance by human leukocytes. II. Comparison of stimulation by antigen, anti-IgE, calcium ionophore, and C5-peptide. J Immunol (1980) 0.92
Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen. J Immunol (1995) 0.91
Synthesis of tentoxin and related dehydro cyclic tetrapeptides. J Org Chem (1978) 0.91
Dihydroergocryptine is a non-selective antagonist for human platelet alpha-adrenoreceptors. Nature (1979) 0.89
N-terminal sequence heterogeneity of guinea pig anti-DNP kappa chains. Immunochemistry (1969) 0.88
Estimating educational casualty from the 1964 rubella epidemic in Maryland. Md State Med J (1972) 0.88
Histamine-releasing activity. IV. Molecular heterogeneity of the activity from stimulated human thoracic duct lymphocytes. Cell Immunol (1984) 0.88
Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med (1995) 0.87
Identification of a histamine release inhibitory factor produced by human mononuclear cells in vitro. J Clin Invest (1988) 0.87
Assessment of Mars Exploration Rover landing site predictions. Nature (2005) 0.86
Recurrent diffuse osteomyelitis involving the mandible. Oral Surg Oral Med Oral Pathol (1984) 0.86
Detection of histamine release inhibitory factor- and histamine releasing factor-like activities in bronchoalveolar lavage fluids. Am Rev Respir Dis (1990) 0.86
Enhancement of basophil chemotaxis in vitro by virus-induced interferon. J Clin Invest (1981) 0.86
N-terminal analysis of normal immunoglobulin light chains. I. A study of thirteen individual humans. Immunochemistry (1971) 0.85
Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog. Results of a double-blind, placebo-controlled randomized study. Am Rev Respir Dis (1993) 0.85
High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans' cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Immunology (1998) 0.84
Reversed in vitro anaphylaxis induced by anti-IgG: specificity of the reaction and comparison with antigen-induced histamine release. J Immunol (1972) 0.84
Activation of basophils. Fed Proc (1986) 0.84
Three weeks of the limited list. Br Med J (Clin Res Ed) (1985) 0.84
Local chemotherapy omaduromycosis caused by Monosporium apiospermum. Arch Intern Med (1969) 0.84
The feasibility of barcode-based dispensing quality assurance programs. Drug Intell Clin Pharm (1984) 0.83
Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism. J Immunol (1985) 0.83
Giant trichobezoar--an unusual case. Scott Med J (1979) 0.83
Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med (1994) 0.83
Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol (1997) 0.83
Sensitivity of basophils to histamine releasing factor(s) of various origin: dependency on allergic phenotype of the donor and surface-bound IgE. J Allergy Clin Immunol (1990) 0.82